Methylseleninic Acid Provided at Nutritional Selenium Levels Inhibits Angiogenesis by Down-regulating Integrin β3 Signaling

Targeting angiogenesis has emerged as a promising strategy for cancer treatment. Methylseleninic acid (MSA) is a metabolite of selenium (Se) in animal cells that exhibits anti-oxidative and anti-cancer activities at levels exceeding Se nutritional requirements. However, it remains unclear whether MS...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Autores principales: Cai, Zhihui, Dong, Liangbo, Song, Chengwei, Zhang, Yanqing, Zhu, Chenghui, Zhang, Yibo, Ling, Qinjie, Hoffmann, Peter R., Li, Jun, Huang, Zhi, Li, Wei
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573405/
https://ncbi.nlm.nih.gov/pubmed/28842587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-09568-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares